Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. All patients under the age of 18 years with intra-abdominal bacterial abscesses requiring percutaneous drain insertion (including transrectal drains).~2. Drain(s) must be inserted within the 23hrs prior to enrollment in the study.~3. The underlying diagnosis of the condition will not affect the enrollment of the patient unless it is detailed within the exclusion criteria (section 4.1.2).~4. Patients and parents must have signed informed consent to participate in the study.~Exclusion Criteria:1.~1. Pancreatic abscess (not bacterial in nature)~2. Known coagulation impairment~3. Known central nervous system tumor or abscesses~4. Arteriovenous malformation~5. Aneurysm or history of central nervous system bleeding~6. Hypersensitivity to tPA~7. Recent administration of an investigational drug (within previous 30 days)~8. Pregnancy~9. Breast-feeding~10. Fulminant hepatic failure~11. Proven fistula (as it will alter the drainage time) or any abscess secondary to Crohn's Disease (because fistula existence cannot be excluded)~12. Necrotizing enterocolitis~13. Children requiring 4 or more drains

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- tPA (Type: EXPERIMENTAL): tissue Plasminogen Activator
- Placebo (Type: PLACEBO_COMPARATOR): Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).